1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Instruments
1.2.3 Reagents
1.2.4 Services
1.2.5 Software
1.3 Market by Application
1.3.1 Global Veterinary Molecular Diagnostics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Clinical Laboratories
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Molecular Diagnostics Market Perspective (2018-2030)
2.2 Veterinary Molecular Diagnostics Growth Trends by Region
2.2.1 Veterinary Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Veterinary Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Molecular Diagnostics Forecasted Market Size by Region (2023-2030)
2.3 Veterinary Molecular Diagnostics Market Dynamics
2.3.1 Veterinary Molecular Diagnostics Industry Trends
2.3.2 Veterinary Molecular Diagnostics Market Drivers
2.3.3 Veterinary Molecular Diagnostics Market Challenges
2.3.4 Veterinary Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Molecular Diagnostics Players by Revenue
3.1.1 Global Top Veterinary Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Veterinary Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Molecular Diagnostics Revenue
3.4 Global Veterinary Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Veterinary Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Molecular Diagnostics Revenue in 2022
3.5 Veterinary Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Veterinary Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Veterinary Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Molecular Diagnostics Breakdown Data by Type
4.1 Global Veterinary Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Molecular Diagnostics Forecasted Market Size by Type (2023-2030)
5 Veterinary Molecular Diagnostics Breakdown Data by Application
5.1 Global Veterinary Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Molecular Diagnostics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Veterinary Molecular Diagnostics Market Size (2018-2030)
6.2 North America Veterinary Molecular Diagnostics Market Size by Country (2018-2023)
6.3 North America Veterinary Molecular Diagnostics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Veterinary Molecular Diagnostics Market Size (2018-2030)
7.2 Europe Veterinary Molecular Diagnostics Market Size by Country (2018-2023)
7.3 Europe Veterinary Molecular Diagnostics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Molecular Diagnostics Market Size (2018-2030)
8.2 Asia-Pacific Veterinary Molecular Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific Veterinary Molecular Diagnostics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Veterinary Molecular Diagnostics Market Size (2018-2030)
9.2 Latin America Veterinary Molecular Diagnostics Market Size by Country (2018-2023)
9.3 Latin America Veterinary Molecular Diagnostics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Molecular Diagnostics Market Size (2018-2030)
10.2 Middle East & Africa Veterinary Molecular Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa Veterinary Molecular Diagnostics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 IDEXX Laboratories
11.1.1 IDEXX Laboratories Company Detail
11.1.2 IDEXX Laboratories Business Overview
11.1.3 IDEXX Laboratories Veterinary Molecular Diagnostics Introduction
11.1.4 IDEXX Laboratories Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.1.5 IDEXX Laboratories Recent Development
11.2 VCA
11.2.1 VCA Company Detail
11.2.2 VCA Business Overview
11.2.3 VCA Veterinary Molecular Diagnostics Introduction
11.2.4 VCA Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.2.5 VCA Recent Development
11.3 BAXIS
11.3.1 BAXIS Company Detail
11.3.2 BAXIS Business Overview
11.3.3 BAXIS Veterinary Molecular Diagnostics Introduction
11.3.4 BAXIS Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.3.5 BAXIS Recent Development
11.4 Heska
11.4.1 Heska Company Detail
11.4.2 Heska Business Overview
11.4.3 Heska Veterinary Molecular Diagnostics Introduction
11.4.4 Heska Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.4.5 Heska Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Detail
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Veterinary Molecular Diagnostics Introduction
11.5.4 Zoetis Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.5.5 Zoetis Recent Development
11.6 Neogen
11.6.1 Neogen Company Detail
11.6.2 Neogen Business Overview
11.6.3 Neogen Veterinary Molecular Diagnostics Introduction
11.6.4 Neogen Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.6.5 Neogen Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Veterinary Molecular Diagnostics Introduction
11.7.4 Thermo Fisher Scientific Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Virbac
11.8.1 Virbac Company Detail
11.8.2 Virbac Business Overview
11.8.3 Virbac Veterinary Molecular Diagnostics Introduction
11.8.4 Virbac Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.8.5 Virbac Recent Development
11.9 GE Healthcare
11.9.1 GE Healthcare Company Detail
11.9.2 GE Healthcare Business Overview
11.9.3 GE Healthcare Veterinary Molecular Diagnostics Introduction
11.9.4 GE Healthcare Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.9.5 GE Healthcare Recent Development
11.10 AGFA Healthcare
11.10.1 AGFA Healthcare Company Detail
11.10.2 AGFA Healthcare Business Overview
11.10.3 AGFA Healthcare Veterinary Molecular Diagnostics Introduction
11.10.4 AGFA Healthcare Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.10.5 AGFA Healthcare Recent Development
11.11 Veterinary Molecular Diagnostics
11.11.1 Veterinary Molecular Diagnostics Company Detail
11.11.2 Veterinary Molecular Diagnostics Business Overview
11.11.3 Veterinary Molecular Diagnostics Veterinary Molecular Diagnostics Introduction
11.11.4 Veterinary Molecular Diagnostics Revenue in Veterinary Molecular Diagnostics Business (2018-2023)
11.11.5 Veterinary Molecular Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
